Lu Yang
Impact in
- Toxicology top 0.2%
- Bioactive Compounds and Antitumor Agents
Papers in
- Pharmacology 10
- Musculoskeletal pain and rehabilitation 4
-
- Advanced Neuroimaging Techniques and Applications 5
- Co-authors
- Xin Chen (5 shared papers)Joost J. Oppenheim (5 shared papers)O. M. Zack Howard (5 shared papers)Robert W. Buckheit (6 shared papers)Jim A. Turpin (1 shared paper)Ning Zhang (1 shared paper)Leen‐Jan van Doorn (1 shared paper)Anneke K. Raney (1 shared paper)
- Journals
- Molecules (3 papers)Journal of Separation Science (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Agricultural and Food Chemistry (3 papers)Stem Cell Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lu Yang
57 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 120
- Toxicology 418
- Complementary and alternative medicine 119
- Virology 55
- Cancer Research 170
- Pharmacology 93
Countries citing papers authored by Lu Yang
This map shows the geographic impact of Lu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yang more than expected).
Fields of papers citing papers by Lu Yang
This network shows the impact of papers produced by Lu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yang. The network helps show where Lu Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 355 | |
| 2 | 2003 | 197 | |
| 3 | 2014 | 188 | |
| 4 | Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity. | 2003 | 77 |
| 5 | 2012 | 50 | |
| 6 | 2014 | 42 | |
| 7 | 2017 | 38 | |
| 8 | 2018 | 34 | |
| 9 | 2002 | 34 | |
| 10 | 2015 | 33 | |
| 11 | 2019 | 30 | |
| 12 | 2016 | 29 | |
| 13 | Dendritic cells as a pharmacological target of traditional Chinese medicine. | 2006 | 27 |
| 14 | 2015 | 26 | |
| 15 | 2023 | 23 | |
| 16 | 2018 | 22 | |
| 17 | 2020 | 22 | |
| 18 | 2014 | 22 | |
| 19 | 2018 | 19 | |
| 20 | 2011 | 19 |
About Lu Yang
Lu Yang is a scholar working on Pharmacology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Neurology and Food Science, having authored 58 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neurological disorders and treatments (5 papers), Advanced Neuroimaging Techniques and Applications (5 papers), Pesticide Residue Analysis and Safety (5 papers), Transcranial Magnetic Stimulation Studies (4 papers), Analytical Methods in Pharmaceuticals (4 papers), Botulinum Toxin and Related Neurological Disorders (4 papers), Musculoskeletal pain and rehabilitation (4 papers) and Traditional Chinese Medicine Analysis (4 papers). The work is most often cited by research in Toxicology (418 citations), Complementary and alternative medicine (119 citations), Virology (55 citations), Cancer Research (170 citations) and Pharmacology (93 citations). Lu Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xin Chen, Joost J. Oppenheim, O. M. Zack Howard, Robert W. Buckheit, Jim A. Turpin, Ning Zhang, Leen‐Jan van Doorn, Anneke K. Raney, Karin Zeh and Todd B. Parsley. Their work appears in journals such as Molecules, Journal of Separation Science, Antimicrobial Agents and Chemotherapy, Journal of Agricultural and Food Chemistry and Stem Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.